Search results
Results from the WOW.Com Content Network
Valsartan includes a black box warning for fetal toxicity. [ 7 ] [ 9 ] Discontinuation of these agents is recommended immediately after detection of pregnancy and an alternative medication should be started. [ 7 ]
The use of valsartan in pregnancy is avoided due to the potential risk of fetal toxicity. [11] The U.S. Food and Drug Administration has a black box warning for valsartan/hydrochlorothiazide use during pregnancy. [2] The use of hydrochlorothiazide is avoided in those with anuria or severe kidney disease. [12]
Iron deficiency is common in pregnancy, with the highest occurrence rate during the third trimester as iron demand increases to support the placenta, fetal development and the iron stores for the first six months after birth. Low iron levels can cause fatigue, reduced work capacity, cardiovascular stress, lower resistance to infection and iron ...
Fetal warfarin syndrome is a disorder of the embryo which occurs in a child whose mother took the medication warfarin (brand name: Coumadin) during pregnancy. Resulting abnormalities include low birth weight , slower growth , intellectual disability , deafness , small head size , and malformed bones , cartilage , and joints .
Developmental toxicity is any developmental malformation that is caused by the toxicity of a chemical or pathogen. It is the structural or functional alteration, reversible or irreversible, which interferes with homeostasis , normal growth , differentiation , development or behavior.
A man has been found guilty of sexual assault and poisoning after covertly plying a pregnant woman with medication to cause a miscarriage. Stuart Worby, 40, was found guilty by a jury on Wednesday ...
Reproductive toxicity refers to the potential risk from a given chemical, physical or biologic agent to adversely affect both male and female fertility as well as offspring development. [1] Reproductive toxicants may adversely affect sexual function, ovarian failure, fertility as well as causing developmental toxicity in the offspring.
A federal appeals court blocked Nasdaq rules to increase boardroom diversity, saying that the Securities and Exchange Commission did not have the authority to approve them.. Wednesday’s ruling ...